Company Filing History:
Years Active: 2025
Title: Innovations by Guangcun Cheng in Antibody Development
Introduction
Guangcun Cheng is a notable inventor based in Shanghai, CN. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic purposes. With a total of 2 patents, Cheng's work is paving the way for advancements in medical treatments.
Latest Patents
Cheng's latest patents include innovative antibodies specific to MUC18, also known as MCAM or CD146. These antibodies are designed for use in antibody-drug conjugates (ADCs) that target MUC18 for therapeutic and diagnostic applications. Additionally, he has developed antibodies that bind specifically to CD44 variant 7/8, which are also utilized in ADCs and chimeric antigen receptors for similar therapeutic and diagnostic purposes.
Career Highlights
Cheng is currently associated with Multitude, Inc., where he continues to push the boundaries of antibody research. His work has garnered attention in the scientific community for its potential impact on cancer treatment and other medical fields.
Collaborations
Cheng collaborates with esteemed colleagues such as Shaofei Zhang and Bing Hou, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Guangcun Cheng's contributions to antibody development represent a significant advancement in biotechnology. His innovative patents and collaborative efforts are set to enhance therapeutic options in the medical field.